United States Pharmacy Benefit Management Market Insights Report 2023-2029 Featuring Key Vendors – CVS, Cigna Healthcare, UnitedHealth Group, Prime Therapeutics, MedImpact, and Humana

DUBLIN, March 21, 2024 /PRNewswire/ — The “U.S. Pharmacy Benefit Management (PBM) Market – Focused Insights 2024-2029” report has been added to ResearchAndMarkets.com’s offering.

The U.S. pharmacy benefit management (PBM) market was valued at USD 491.88 billion in 2023 and is expected to reach a value of $680.73 billion by 2029, growing at a CAGR of 5.56% from 2023-2029.

The U.S. pharmacy benefit management (PBM) market report includes exclusive data on 27 vendors. CVS Health, Cigna Healthcare, United Health Group, Prime Therapeutics, MedImpact, and Humana dominate the U.S. Pharmacy Benefit Management market. The major players focus on strategic acquisitions and collaborations with emerging players to enter the pharmacy benefit management market and gain a competitive advantage. 

The southern region dominated the segment of the U.S. pharmacy benefit management (PBM) market, with a share of 30% in 2023. The growth of this region is due to the presence of high rates of chronic disease and poor health conditions, as well as a high percentage of insurers in the southern states. Kentucky, West Virginia, Virginia, and Louisiana are the top states with a high percentage of insurers among the southern states in the U.S.

MARKET TRENDS

Specialty drugs Continuing to Drive Rx Spend: Specialty drugs represent the fastest-growing area of pharmacy spend. Over the years, specialty drug growth has been driven by adopting innovative drugs, such as those for oncology and autoimmune therapies. According to the IQVIA Institute, 50-55 new specialty drugs will be launched annually over the next four years.

Specialty drugs will continue evolving, helping cure or curb symptoms for patients with complex or chronic medical conditions. As new drugs hit the market and prices continue to rise, health plan sponsors will continue to look to their pharmacy benefit management markets (PBMs) to help address the cost and accessibility of prescription drugs.

The Growth Of Innovative PBM Pricing Strategies: The continued evolution of the pharmacy benefit management (PBM) market contracting model and pricing strategies is expected to continue. For example, to counteract the high prices of specialty drugs, PBMs are embracing outcomes-based contracting. According to a recent national healthcare consulting firm study, 58% of payers had entered outcomes-based contracts as of 2022. Another alternative PBM pricing strategy includes the growing use of innovative utilization tools.

U.S. PHARMACY BENEFIT MANAGEMENT MARKET HIGHLIGHTS

The medicare plan of health plan segment is growing significantly, with the fastest-growing CAGR of 6.74% during the forecast period. The growth of this segment is attributed to several factors, which include a shift towards virtual care delivery, more home care, and the adoption of value-based care models.The insurance companies & retail pharmacies segment dominates the share with over 75% of the U.S. pharmacy benefit management (PBM) market. Many reasons, including the expanding access to testing and diagnosis and growing awareness among the general population across the U.S., contribute to the growth of this segment.The claim processing in the service segment is the fastest-growing in the U.S. pharmacy benefit management (PBM) market during the forecast period. The growth of this segment is mainly due to the benefits it offers from pharmacy benefit management (PBM) market claims auditing, which monitors payment integrity and fraud, waste, abuse of health plans, employers, Medicare Advantage Part D plans, brokers, Taft-Hartley funds, and other pharmacy plans.

KEY QUESTIONS ANSWERED

How big is the U.S. pharmacy benefit management market?What is the growth rate of the U.S. pharmacy benefit management market?Who are the dominating players in the U.S. pharmacy benefit management market?

VENDORS LIST

Key Vendors

CVS HealthCigna HealthcareUnitedHealth GroupPrime TherapeuticsMedImpactHumana

Other Prominent Vendors

AbarcaElevance HealthAscellaHealthCaptureRxCenteneChange HealthcareCitizensRxElixirMedalistRxMaxorPlusNavitus Health SolutionsPerformRxWellDyneProCare RxNirvanaHealthAnthemBeneCard PBMShields Health SolutionsMagellan Rx ManagementWalgreens Boots AllianceRITE AID

Segmentation & Forecast

By Health Plan

Commercial Health PlansMedicare PlanMedicaid PlanOthers

By Business Model

Insurance Companies & Retail PharmaciesPure Play PBMs

By Service

Special Pharmacy ServicesRetail Pharmacy NetworksMail-order pharmacy servicesClaims ProcessingFormulary ManagementDrug Utilization ReviewPrice, Discount & Rebate NegotiationsDisease Management & Adherence Initiatives

By Region

SouthMid-WestWestNortheast

For more information about this report visit https://www.researchandmarkets.com/r/htjruf

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact:

Laura Wood, Senior Manager
[email protected] 
 
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
 
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

 

View original content:https://www.prnewswire.com/news-releases/united-states-pharmacy-benefit-management-market-insights-report-2023-2029-featuring-key-vendors—cvs-cigna-healthcare-unitedhealth-group-prime-therapeutics-medimpact-and-humana-302095731.html

SOURCE Research and Markets